The Novotech team is looking forward to meeting you at the ESMO Congress 2022 in Paris.
Submit the form and set up a meeting with a Novotech expert if you wish to hear more about the world’s fastest growing region in clinical development.
If you are considering Asia or Australia for your clinical trials, it would be a great opportunity to connect during ESMO to learn more about your plans and see if/how we can support your clinical development plans over 2022 and beyond. Australia is a very attractive destination for early phase clinical trials (43.5% cash rebate on clinical trial expenses, rapid start-up with no IND required), while Asia and in particular China offers access to large patient pools and potential end markets.
Stop by to meet our Business Development team, who will be happy to answer any questions you might have and discuss how Novotech can best support your clinical studies.
Novotech has provided CRO services across a broad range of indications and treatment modalities including Oncology CRO services, Infectious diseases CRO services, Vaccines CRO services and Orphan CRO services.
Novotech has partnered with some of the leading medical institutions in the region. The Partnership Program is strategically designed to bring unparalleled access to quality investigators, key opinion leaders, and up to 4 billion patients for its international biotech clients.
BioDesk is Novotech’s in-house intelligent global product development and regulatory affairs consultancy comprising of a preclinical regulatory group of subject matter experts. From inception, through development and to approval, BioDesk is with you at every step.